Smith & Nephew (LON:SN) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why

Shares of Smith & Nephew plc (LON:SN) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,242.25 and traded as high as GBX 1,269.50. Smith & Nephew shares last traded at GBX 1,263, with a volume of 1,366,948 shares traded.

Wall Street Analyst Weigh In

A number of research firms have weighed in on SN. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Smith & Nephew in a research note on Friday, November 7th. Royal Bank Of Canada lifted their target price on Smith & Nephew from GBX 1,400 to GBX 1,700 and gave the company an “outperform” rating in a report on Monday, October 20th. Deutsche Bank Aktiengesellschaft boosted their price target on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a “hold” rating in a research report on Wednesday, August 6th. Citigroup raised their price objective on Smith & Nephew from GBX 1,450 to GBX 1,600 and gave the stock a “buy” rating in a report on Friday, October 31st. Finally, Berenberg Bank lifted their price objective on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the company a “hold” rating in a research note on Thursday, August 7th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of GBX 1,487.60.

Smith & Nephew Stock Performance

The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51. The stock has a fifty day simple moving average of GBX 1,323.16 and a two-hundred day simple moving average of GBX 1,243.57. The stock has a market cap of £13.75 billion, a PE ratio of 45.17, a PEG ratio of 0.46 and a beta of 0.62.

Insider Buying and Selling at Smith & Nephew

In related news, insider Deepak Nath sold 1,240 shares of the firm’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of GBX 1,257, for a total transaction of £15,586.80. Company insiders own 0.19% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.